Vertaling van "prior " (Nederlands → Frans) :

checked prior to publication. Radio and television advertisements are provided with a licence after advice from the Commission for the supervision of advertising of medicines for human use or after notification to the FAMHP for the other media.
checked prior to publication. Radio and television advertisements are provided with a licence after advice from the Commission for the supervision of advertising of medicines for human use or after notification to the FAMHP for the other media.

The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.
The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.

In terms of premiums and benefits, since 1 January 2007 there has been a requirement to request a prior licence when a pharmaceutical company or company selling medical devices wishes to pay the costs of a healthcare professional participating in a scientific gathering including at least one overnight stay.
In terms of premiums and benefits, since 1 January 2007 there has been a requirement to request a prior licence when a pharmaceutical company or company selling medical devices wishes to pay the costs of a healthcare professional participating in a scientific gathering including at least one overnight stay.

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.

In het kader van de internationale handel, wordt de afkorting PIC (Prior Informed Consent) gebruikt voor de procedure voor informatie-uitwisseling tussen invoerende en uitvoerende landen over bepaalde chemische producten.
Dans le cadre du commerce international, l‘abréviation PIC (Prior Informed Consent) est utilisée pour désigner une procédure d'échange d'informations entre les pays exportateurs et importateurs à propos de certains produits chimiques.

De term PIC staat voor Prior Informed Consent (betekent zoveel als “voorafgaande geïnformeerde toestemming”) en verwijst naar een procedure voor de uitwisseling van informatie omtrent bepaalde giftige chemische stoffen, in het kader van de import en export van dergelijke stoffen.
Le terme PIC, qui signifie Prior Informed Consent, désigne une procédure d'échange d'informations à propos de certains produits chimiques toxiques, et ceci dans le cadre d’importation / exportation desdits produits.

Tasigna (USD 144 million, +171% lc) is approved in 65 countries as a second-line therapy for patients with a form of chronic myeloid leukemia (CML) resistant or intolerant to prior therapy, including Gleevec/Glivec.
Tasigna (USD 114 millions, +171% en m. l) est autorisé dans 65 pays en tant que traitement de deuxième ligne pour les malades atteints d’une forme de leucémie myéloïde chronique (LMC) présentant une résistance ou une intolérance aux traitements antérieurs, Glivec/Gleevec inclus.

31-okt-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » meer
31-oct.-2013 Bayer continues positive business momentum Ongoing dynamic trend in Life Sciences; MaterialScience level with prior-year quarter / New pharmaceutical products post excellent growth / Group sales EUR 9,643 million (minus 0.2 percent; Fx & portfolio adj. plus 6.0 percent) / EBIT shows 47.5 percent improvement to EUR 1,221 million / EBITDA before special items moves 7.7 percent higher to EUR 1,984 million / Net income advances by 42.1 percent to EUR 733 million / Core earnings per share up 8.5 percent to EUR 1.27 / Group guidance for 2013 maintained » En savoir plus

Terug naar " Prior Informed Consent (PIC)"
Retour à " Prior Informed Consent (PIC)"

7. Genève UNECE United Nations Economic Commission for Europe www.unece.org/env PIC Convention on the Prior Informed Consent Procedure of Hazardous Chemicals and Pesticides www.pic.net POPs Convention on Persistant Organic Pollutants www.pops.int THE PEP Transport, Health and Environment Pan-European Programme www.thepep.org
7. Geneva UNECE United Nations Economic Commission for Europe www.unece.org/env PIC Convention on the Prior Informed Consent Procedure of Hazardous Chemicals and Pesticides www.pic.net POPs Convention on Persistant Organic Pollutants www.pops.int THE PEP Transport, Health and Environment Pan-European Programme www.thepep.org